DermaLabs blends dermatologist-led science with community-powered research. Using decentralized trials, AI imaging, and SKIN token incentives, we turn everyday skincare into measurable evidence. Together, we build transparent, inclusive, and accountable pathways for discovering and validating what truly works for your skin.

GoCART Therapeutics is building a new generation of safer, smarter cell therapies for cancer. Our technology uses a biological 'AND-gate'—a two-key safety system that only activates its 'kill' signal when it detects two distinct targets on a cancer cell. This logic-gated approach dramatically reduces the toxicity risks of current CAR-T therapies.

We are developing a new gene therapy to help our canine companions stay stronger, move more comfortably, and enjoy healthier lives as they age. By supporting muscle growth, easing pain, and calming inflammation linked to arthritis, our follistatin therapy aims to improve everyday mobility and overall wellbeing.

As we age, our bodies accumulate senescent, or “zombie", cells which are highly damaged, yet refuse to die. They disrupt tissue homeostasis, are toxic to neighboring cells and are associated with numerous age-related diseases. This project will utilize CRISPR gene-editing technology to find genes that are essential for keeping senescent cells alive, thus providing new drug targets to selectively eliminate them.

We’re building a safe, affordable, and ethically sourced ibogaine therapy for PTSD—using synthetic production, personalized protocols, and transparent governance to make effective treatment accessible worldwide.

Nootropics DAO is building the world's most effective global infrastructure for decentralized research, discovery, and commercialization of powerful solutions for human cognitive enhancement. By creating an open-science ecosystem that aligns professional researchers, citizen-scientists, and biohackers to govern a community-directed research and development pipeline with hyper-efficient feedback loops, Nootropics DAO is operating to become the dominant force in the rapidly growing nootropics industry.

PeptAI is an autonomous AI agent that discovers new peptide drug candidates. It designs peptides computationally, then pushes them through an 8-gate validation pipeline. Every result is published on-chain (blockchain) so anyone can verify the science. Once a candidate passes validation, it's sent to the wet-lab for synthesis and binding assays. PeptAI is receptor agnostic, however first programmes target GLP1R, KISS1R, OX2R and several other GPCRs.

The first human trial that will tell you - with blood - which training actually grows your brain. 100 Berlin gym-goers. 2 training arms. 200+ BDNF blood draws. All data on-chain in real time. All revenue and dataset usage feed the Bio Protocol’s buyback & research-funding loop. 4300+ workouts already tracked. Now we ignite the next stage to reach longevity orbit.

This project will design a new RNA therapeutic that nudges the longevity-linked FOXO3 gene into its health-promoting form to halt the tissue breakdown behind degenerative disc disease—opening a precise, scalable route to drugs that extend healthspan.

Relieva is redefining therapeutic innovation through the world’s first proprietary cannabis and hemp pre-roll blend engineered for targeted pain relief. Leveraging advanced cannabinoid and terpene research, Relieva integrates scientific precision, sustainable production, and blockchain-enabled IP tokenization to establish a new benchmark in functional medicine innovation and therapeutic transparency.

The galectin-3 Inhibitors project tests a small molecule under development for peripheral indications for treating neuroinflammation in an Alzheimer’s mouse model. By blocking galectin-3, it aims to reduce brain inflammation, with potential in other neurodegenerative diseases. Galectin-3 is involved in neuroinflammation, thereby the inhibitor has a potential to be used in multiple neurodegenerative diseases.

D1ckGPT is a BioAgent that makes your D1ck stronger by assessing its age and guiding you on how to reverse it. Trained on 600+ clinician-curated studies with its own Decentralized Knowledge Graph, every interaction enhances D1ckGPT's intelligence, revolutionizing traditional care and accelerating science and drug discovery in men's health. Whether it’s optimizing testosterone, boosting cognitive edge, or getting smarter about longevity.